Securian Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
DLA
OIAM
YIH
CNB
COPPSERS
AB
PFSRSONJ
Securian Asset Management's MRNA Position: Q2 2026 in Review
Securian Asset Management increased its Moderna (MRNA) stake by 0.32% in Q2 2026, buying an estimated $1.55K and bringing the position to 9,384 shares worth $580K. The position accounts for 0.02% of the portfolio, ranked #582.
Securian Asset Management first reported a position in MRNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $11.5M in Q3 2021. 164 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Securian Asset Management held 9,384 shares of Moderna worth $580K as of Q2 2026.
- Securian Asset Management bought 30 Moderna shares in Q2 2026, an estimated $1.55K.
- Moderna made up 0.02% of Securian Asset Management's portfolio in Q2 2026, its #582 holding.
- Securian Asset Management first reported a position in Moderna in Q3 2021 and has held it in 20 quarters since.
- Securian Asset Management's Moderna position peaked at $11.5M in Q3 2021.
- 164 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.